News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
47 Results
Type
Article (4)
Press Release (43)
Section
Business (4)
Deals (1)
Drug Development (13)
FDA (3)
Job Trends (1)
News (23)
Policy (5)
Tag
Alliances (4)
Approvals (3)
Best Places to Work (1)
Clinical research (10)
Events (1)
FDA (3)
Government (1)
Mergers & acquisitions (1)
Phase 2 (3)
Phase 3 (7)
Pipeline (1)
Postmarket research (2)
Preclinical (2)
Regulatory (5)
Date
Last 365 days (2)
2025 (2)
2024 (3)
2022 (2)
2021 (3)
2020 (8)
2019 (3)
2018 (1)
2017 (1)
2016 (3)
2014 (2)
2013 (1)
2012 (3)
2011 (5)
2010 (4)
Location
Asia (20)
Australia (35)
Europe (14)
47 Results for "clinuvel".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies
December 8, 2025
·
7 min read
Press Releases
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
September 29, 2025
·
6 min read
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE® and the future of photomedicine.
March 28, 2024
·
2 min read
CLINUVEL Expands Pharmaceutical Portfolio
CLINUVEL has expanded its pharmaceutical development portfolio with NEURACTHEL®, novel formulations of the melanocortin adrenocorticotropic hormone.
November 7, 2021
·
4 min read
Drug Development
Afamelanotide in fair-skinned Parkinson’s patients
CLINUVEL announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease in fair-skinned patients.
June 17, 2024
·
6 min read
CLINUVEL expands DNA Repair Program
CLINUVEL has expanded its clinical program to evaluate the DNA reparative potential of afamelanotide in skin cells which have been damaged by ultraviolet (UV) and sun exposure.
March 23, 2021
·
5 min read
PRÉNUMBRA® - CLINUVEL’s Second Afamelanotide FormulationDrug to be evaluated in patients with acute and systemic diseases
CLINUVEL PHARMACEUTICALS revealed PRÉNUMBRA®, the Company’s second afamelanotide product in development.
July 13, 2020
·
7 min read
CLINUVEL Opens VALLAURIX R&D Centre In SingaporeBespoke Research & Development Centre to advance innovative pharmaceutical and OTC products
The CLINUVEL Group announced the opening of its state-of-the-art centralised Research & Development Centre in Singapore, operated by CLINUVEL subsidiary VALLAURIX PTE Ltd.
August 31, 2020
·
7 min read
CLINUVEL progresses innovative DNA Repair ProgramDrug tested to protect skin and regenerate DNA, firstly in XP patients at 10,000-fold skin cancer risk
CLINUVEL PHARMACEUTICALS LTD announced the progression of its drug SCENESSE® to treat the disease xeroderma pigmentosum.
September 10, 2020
·
7 min read
CLINUVEL to Trial Innovative Drug in Stroke
The drug afamelanotide will be used for the first time in patients with acute stroke.
October 27, 2020
·
5 min read
1 of 5
Next
